Multidisciplinary Care — Team-Based Cancer Treatment

Multidisciplinary care is an integrated clinical framework wherein diverse medical specialists and allied healthcare professionals jointly formulate and deliver a patient's comprehensive management plan. Central to this process is the multidisciplinary team (MDT) meeting, sometimes called a tumour board.

During these regular meetings, medical oncologists, surgical oncologists, radiation oncologists, radiologists, histopathologists, and clinical nurse specialists review patient diagnostic data, imaging, and pathology reports. Together, they evaluate clinical guidelines, discuss potential therapeutic approaches, and agree upon an evidence-based, consensus-driven treatment pathway tailored to each patient's specific presentation.

Receiving care through a multidisciplinary team ensures that every therapeutic option is thoroughly evaluated by the appropriate specialist before decisions are finalised. Studies show that team-based management leads to more accurate staging, better adherence to evidence-based clinical guidelines, and timely transitions between different phases of treatment. For patients and families, it reduces the burden of having to navigate fragmented services independently and ensures seamless communication across the entire oncology care journey.

Multidisciplinary care is not a biological marker, but the framework through which all biomarkers and tests are reviewed. The team's pathologist presents molecular and genomic testing, while the radiologist reviews CT, MRI, and PET scans, enabling the entire team to integrate laboratory findings directly into clinical decision-making.

Multidisciplinary care is standard practice across all cancer types and stages. It is particularly essential in complex presentations, such as locally advanced head and neck, breast, lung, gastrointestinal, and gynaecological cancers, as well as rare malignancies and blood cancers requiring sequential multimodal interventions.

The MDT establishes the sequence of treatments, such as deciding whether neoadjuvant chemotherapy or radiation should precede surgery, or whether clinical trial enrolment is appropriate. The team also coordinates supportive services, including physiotherapy, nutritional guidance, pain management, and psychological support.